Trials / Completed
CompletedNCT01480336
The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot
The Pharmacokinetics and Electrocardiographic Implications of Adjunctive Amiodarone and Ranolazine Therapy in Patients on Implantable Cardioverter Defibrillators: The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Hartford Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to learn if combination therapy with amiodarone and ranolazine (an approved drug for chest pain) can help prevent arrhythmias.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amiodarone Plus Ranolazine | Ranolazine 500mg by mouth twice daily |
| DRUG | Amiodarone with Placebo | stabel dose of amiodarone as prescribed by cardiologist |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2011-11-28
- Last updated
- 2013-03-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01480336. Inclusion in this directory is not an endorsement.